Global Transplant Diagnostics Market

The global transplant diagnostics market is growing at a high CAGR because of the increasing prevalence of various acute and chronic diseases, resulting in rising cases of organ failure, as a result, the demand for organ transplant surgeries is increasing at a high rate. Furthermore, rising consciousness among people factoring in the increasing rate of organ donation is also influencing the growth of the market. However, the huge gap between demand and supply of organs may act as a huge restraining factor for the market.

The global transplant diagnostics market was worth USD 3,809.52 million in 2021 and is expected to increase at a CAGR of 7.4% in 2022–2029 to reach USD 6,715.52 million.

Global Transplant Diagnostics Market Segmentation

 Transplant Diagnostics Market Segmentation

Impact of COVID-19

The COVID-19 pandemic has not only presented challenges but also several opportunities. Supply chain disruptions of medical devices/equipment’s and essential medical supplies were prominent in 2020, especially due to travel and trade restrictions all over the globe. Also, to prevent the rapid spread of COVID-19 globally. This resulted in a moderate impact on specific segments of the market.

Global Transplant Diagnostics Market

Transplant diagnostics refers to a diagnostic procedure divided generally done pre- and post-transplantations. It helps in analyzing the patient’s health conditions. If avoided, the individual with weak immunity runs the risk of acquiring Healthcare-Associated Infections (HAIs) or worse which could be fatal. The procedure is known to be a harmonious collaboration between healthcare professionals and laboratory experts ensuring improved patient outcomes. In addition, a close match between a donor and recipient Human Leukocyte Antigen (HLA) marker is essential. It increases the probability of graft survival and minimizes severe immunological transplant complications.

Dominant Market Segment

  • Based on products, the market is segmented into instruments, reagents, and software. Currently, the instruments segment generates maximum revenue. The increasing need for organ transplants creates a demand for transplant diagnostics. In addition, the majority of the transplant diagnostic manufacturers and distributors focus more on emerging markets due to the potential they hold.
  • Additionally, an increase in public and private investments to develop novel HLA products for testing, the soaring number of HLA applications in diagnostics, improvement in healthcare infrastructure, especially in developing nations, consistent reduction average gene sequencing costs, and rising bases of installation of Next-Generation Sequencing (NGS) and Polymerase Chain Reaction (PCR) instruments are steering the market growth.
  • Developed regions such as North America and Western Europe, naturally, also witness strong government support to the medical sector, but the high volume of unmet demand in developing countries is likely to provide significant thrust to the market. The rising investment in medical sector from private sector is also vital for the market, as advanced medical fields such as transplant diagnostics are likely to receive significant investment in the coming years and require steady funding before an economy of scale can be established.

Drivers, Restraints, Opportunities and Challenges of Global Transplant Diagnostics Market

Global Transplant Diagnostics Market

Drivers

Growing Transplant Procedures

Transplantation is one of the preferred treatment options for many patients suffering from end-stage renal disease and undergoing chronic dialysis therapy. Also, transplantation is a viable option considered in cases associated with the heart, liver, and bone marrow. Additionally, in the past decade, diagnostics have improved significantly as companies have been committed to develop better HLA typing technologies, antibody monitoring, instruments, and software. This is gradually being used for diagnostics during the transplantation of different organs of the body.

For instance,

  • In January 2021, according to the data published by the Association of Organ Procurement Organizations (AOPO), more than 12,500 people donated one or more organs in 2020, 6% more from the previous year.
  • Also, the number of organs donated from dead donors increased to over 36,500 in 2020, which is almost a 2% increase year over year. It also reported that in the past seven years, organs from the dead have saved more than 33,000 lives, exceeding the previous year's totals.

Hence, there is significant rise in the transplant procedure seen across the globe and rise in organ donation creates the need for increased transplant diagnostic testing thereby driving the market growth.

Increasing Geriatric Population

  • As per the World Health Organization (WHO) report, it is reported that between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%.
  • By 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion in 2030. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.
  • In 2021, United Health Foundation, stated that more than 54 million adults aged 65 and older live in the U.S., according to U.S. Census Bureau, which accounts for 16.5% of the nation's entire population. It is also forecasted to reach 85.7 million roughly to be 20% of the entire population of the U.S. by year 2050.

  • The share of aged population (>65 years) is expected to increase to 7% (100 million) of the total population in India by 2020, compared to 5% (60 million) in 2010. This would result in a much higher need for healthcare facilities around the globe and is boosting the overall market growth.

Increasing Number of Patients Suffering from Chronic Diseases

  • According to the WHO, chronic disease prevalence is expected to rise by 57% by the year 2025. Globally, approximately one in three of all adults suffer from Multiple Chronic Conditions (MCCs).
  • As per the National Center for Biotechnology Information (NCBI) report, nearly half (approximately 45%, or 133 million) of all Americans suffer from at least one chronic disease, and the number is growing. Therefore, people with such diseases lead to organ failure and this is creating an upsurge in demand for transplant procedures.

Technological Advancements

  • The increase in technological advancements in the field of transplant diagnostics accelerate the market growth. Next Generation Sequencing (NGS) technology is rapidly replacing traditional diagnostic methods, such as serological techniques employed in Human Leukocyte Antigen (HLA) typing, owing to demand for high-throughput diagnostic tools with enhanced accuracy.

Opportunities

Rising Healthcare Expenditure

Healthcare expenditure has increased across the world as people's disposable income in various countries is increasing. Moreover, to accomplish population requirements, the government bodies and healthcare organizations are taking the initiative by virtue of accelerating healthcare expenditure.

For instance,

  • In December 2020, WHO report stated, the global healthcare expenditure is rising in 2018, which was USD 8.3 trillion, which is around 10% of GDP (USD1.080 per citizen) compared to USD 7.6 trillion in 2016. Moreover, global health spending grew by 3.9 percent in real terms between 2000 and 2017.
  • In October 2020, MedTech Europe Organization's report stated that the overall healthcare expenditure in Europe has grown to reach approximately 10% of the GDP in 2020, which was 8.3% GDP in the year 2019 out of which 76.6% is spent on inpatient and outpatient care.

Growing healthcare expenditure is also beneficial for further economic growth and healthcare sector growth, and it is primarily fruitful as it significantly affects the development of better and advanced diagnostic treatments in the market. Thereby surge in healthcare expenditure is a great opportunity for the market.

Strategic Initiatives by Major Players

The transplant procedure is increasing owing to the technological advancements in the market. The top market players have implemented certain strategies which are aimed at enhancing the business operations and profitability in the transplant diagnostics market. The companies have adopted certain strategies such as acquisition, partnerships, product launch, and other strategies for creating opportunities in the market.

  • In September 2021, Thermo Fisher Scientific Inc. added two new products to its transplant diagnostics portfolio during the American Society for Histocompatibility and Immunogenetics (ASHI) annual conference.
  • Care Dx (U.S.) acquired XynManagement (U.S.) in August 2019. The acquisition was done to simplify transplant quality tracking and waitlist management.

Restraints

High Cost of Transplant

High procedural cost of NGS-based and PCR-based diagnostic assays and limited reimbursements for target procedures are expected to obstruct market growth. Also the lack of awareness about transplant diagnostics is expected to hinder the market growth.

Challenges

The Significant Gap Between the Number of Organ Donors and Organs Required

For the transplant annually across the globe is one of the biggest challenge for the market growth. Additionally, some social and ethical issues related to organ transplant can be a challenge to the market growth.

Players covered

List of Transplant Diagnostic Manufacturers:

The top players operating in the market are Immucor Transplant Diagnostics Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Hoffman-La Roche Ltd. (Switzerland), GenDx (Netherlands), CareDx (U.S.), Affymetrix Inc. (U.S.), Linkage Biosciences (U.S.), Becton Dickinson and Company (U.S.), Bio-Rad Inc. (U.S.), Illumina Inc. (U.S.), Abbott Laboratories Inc. (U.S.), bioMérieux S.A. (France), QIAGEN NV (Netherlands), and Omixon Ltd. (U.K.) among others.

Related Reports

  • North America Transplant Diagnostics Market – Industry Trends and Forecast to 2029.
  • Europe Transplant Diagnostics Market - Industry Trends and Forecast to 2029.